the staff's "dearth of knowledge" about the correct procedure to follow when someone dies unexpectedly was also highlighted..jeffrey krasner is president of emerging biocommunications, which consults to early- and mid-stage life science companies.. . january 2018 (23). taking ustekinumab�a biologic that targets a different aspect of the immune system," gelfand said.